What is the latest LAURUSLABS stock price?
The latest stored price for LAURUSLABS is Rs 2,220.00 as of 2026-11-16.
LAURUS LABS LIMITED is a mid-cap stock in Healthcare. This Gimli page shows the latest available LAURUSLABS price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for LAURUSLABS is Rs 2,220.00 as of 2026-11-16.
LAURUSLABS is above 50DMA, above 200DMA. The latest 50DMA is 2,081.47 and the latest 200DMA is 1,514.68.
LAURUSLABS has PE 89.96, ROE +26.71%, and ROCE +25.16% in Gimli's latest available snapshot.
LAURUSLABS has returned +7.76% over 1 month, +24.21% over 3 months, and +122.22% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 2,206.37 cr | 763.31 cr | 441.48 cr | 8.17 |
| 2026-06-30 | 2,026.31 cr | 647.45 cr | 367.60 cr | 6.81 |
| 2026-03-31 | 1,811.57 cr | 523.91 cr | 279.14 cr | 5.17 |
| 2025-12-31 | 1,778.29 cr | 485.97 cr | 251.66 cr | 4.67 |
| 2025-09-30 | 1,680.00 cr | 430.22 cr | 193.75 cr | 3.61 |
| 2025-06-30 | 1,569.57 cr | 392.56 cr | 163.02 cr | 3.02 |
| 2025-03-31 | 1,720.30 cr | 479.17 cr | 233.67 cr | 4.34 |
| 2024-12-31 | 1,415.05 cr | 294.57 cr | 92.30 cr | 1.71 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 6,721.23 cr | 1,822.98 cr | 888.79 cr | 16.47 |
| 2025-03-31 | 5,507.86 cr | 1,120.98 cr | 358.32 cr | 6.65 |
| 2024-03-31 | 5,001.80 cr | 792.70 cr | 160.55 cr | 2.98 |
| 2023-03-31 | 6,014.22 cr | 1,555.91 cr | 790.11 cr | 14.69 |
| 2022-03-31 | 4,728.59 cr | 1,411.10 cr | 750.09 cr | nan |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 10,511.19 cr | 112.65 cr | 2,518.48 cr | 5,431.36 cr |
| 2025-03-31 | 9,335.57 cr | 99.54 cr | 2,763.73 cr | 4,602.52 cr |
| 2024-03-31 | 8,387.03 cr | 138.94 cr | 2,577.40 cr | 4,115.57 cr |
| 2023-03-31 | 7,660.40 cr | 45.67 cr | 2,015.09 cr | 4,048.66 cr |
| 2022-03-31 | 6,968.04 cr | 75.58 cr | 1,776.66 cr | 3,359.05 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 1,623.50 cr | 553.55 cr | n/a |
| 2025-03-31 | 601.65 cr | -39.35 cr | n/a |
| 2024-03-31 | 665.69 cr | -12.62 cr | n/a |
| 2023-03-31 | 993.90 cr | 3.74 cr | n/a |
| 2022-03-31 | 911.10 cr | 34.26 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +27.47% | +30.84% | +11.86% | +8.26% | +29.83% | +2.19% |
| 2026-06-30 | +27.47% | +28.00% | +13.74% | +10.15% | +30.78% | +2.69% |
| 2026-03-31 | +27.49% | +25.82% | +13.97% | +11.22% | +32.71% | +2.69% |
| 2025-12-31 | +27.49% | +26.52% | +12.43% | +9.49% | +33.56% | +2.69% |
| 2025-09-30 | +27.59% | +26.16% | +11.73% | +8.53% | +34.51% | +2.69% |
| 2025-06-30 | +27.59% | +25.70% | +11.94% | +7.78% | +34.77% | +2.69% |
| 2025-03-31 | +27.62% | +25.52% | +11.77% | +6.88% | +35.09% | +2.69% |
| 2024-12-31 | +27.62% | +25.56% | +12.74% | +7.62% | +34.08% | +2.69% |
| 2024-09-30 | +27.18% | +26.08% | +13.05% | +8.25% | +33.69% | +0.00% |
| 2024-06-30 | +27.18% | +25.67% | +13.56% | +9.18% | +33.59% | +0.00% |
| 2024-03-31 | +27.19% | +25.97% | +11.77% | +6.68% | +35.07% | +0.00% |
| 2023-12-31 | +27.19% | +25.39% | +11.14% | +5.58% | +36.29% | +0.04% |
| 2023-09-30 | +27.20% | +24.03% | +11.01% | +5.29% | +37.76% | +0.04% |
| 2023-06-30 | +27.20% | +22.52% | +10.35% | +5.14% | +39.93% | +0.04% |
| 2023-03-31 | +27.20% | +22.42% | +9.74% | +5.40% | +40.64% | +0.04% |
| 2022-12-31 | +27.20% | +21.90% | +9.51% | +5.41% | +41.39% | +0.04% |
| 2022-09-30 | +27.27% | +22.67% | +9.33% | +5.50% | +40.73% | +0.04% |
| 2022-06-30 | +27.27% | +0.00% | +31.09% | n/a | n/a | +0.04% |
| 2022-03-31 | +27.27% | +0.00% | +30.38% | n/a | n/a | +0.00% |
| 2021-12-31 | +27.27% | +0.00% | +28.98% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
| MANKIND | MANKIND PHARMA LIMITED | 108,433.48 cr | 47.905015 | +14.41% | +15.86% |
Data snapshot: 2026-11-16. Not investment advice.